vs

Side-by-side financial comparison of FVCBankcorp, Inc. (FVCB) and SurgePays, Inc. (SURG). Click either name above to swap in a different company.

FVCBankcorp, Inc. is the larger business by last-quarter revenue ($16.9M vs $16.2M, roughly 1.0× SurgePays, Inc.). On growth, FVCBankcorp, Inc. posted the faster year-over-year revenue change (4377.5% vs 68.7%). Over the past eight quarters, FVCBankcorp, Inc.'s revenue compounded faster (586.6% CAGR vs -28.2%).

FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.

SurgePays, Inc. is a U.S.-headquartered fintech and telecommunications company focused on serving underbanked and low-income communities across the country. It offers prepaid wireless plans, reloadable debit cards, digital banking solutions, and daily consumer products through a nationwide network of independent local retail partners such as convenience stores.

FVCB vs SURG — Head-to-Head

Bigger by revenue
FVCB
FVCB
1.0× larger
FVCB
$16.9M
$16.2M
SURG
Growing faster (revenue YoY)
FVCB
FVCB
+4308.8% gap
FVCB
4377.5%
68.7%
SURG
Faster 2-yr revenue CAGR
FVCB
FVCB
Annualised
FVCB
586.6%
-28.2%
SURG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FVCB
FVCB
SURG
SURG
Revenue
$16.9M
$16.2M
Net Profit
$-13.9M
Gross Margin
-14.8%
Operating Margin
43.7%
-79.1%
Net Margin
-85.6%
Revenue YoY
4377.5%
68.7%
Net Profit YoY
30.0%
EPS (diluted)
$0.31
$-0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FVCB
FVCB
SURG
SURG
Q4 25
$16.9M
$16.2M
Q3 25
$416.0K
$18.7M
Q2 25
$15.8M
$11.5M
Q1 25
$382.0K
$10.6M
Q4 24
$378.0K
$9.6M
Q3 24
$412.0K
$4.8M
Q2 24
$415.0K
$15.1M
Q1 24
$359.0K
$31.4M
Net Profit
FVCB
FVCB
SURG
SURG
Q4 25
$-13.9M
Q3 25
$5.6M
$-7.5M
Q2 25
$5.7M
$-7.1M
Q1 25
$5.2M
$-7.6M
Q4 24
$-19.8M
Q3 24
$4.7M
$-14.3M
Q2 24
$4.2M
$-12.9M
Q1 24
$1.3M
$1.2M
Gross Margin
FVCB
FVCB
SURG
SURG
Q4 25
-14.8%
Q3 25
-13.9%
Q2 25
-23.0%
Q1 25
-27.8%
Q4 24
-117.0%
Q3 24
-164.2%
Q2 24
-22.8%
Q1 24
26.0%
Operating Margin
FVCB
FVCB
SURG
SURG
Q4 25
43.7%
-79.1%
Q3 25
-37.2%
Q2 25
45.9%
-59.1%
Q1 25
-71.7%
Q4 24
-209.0%
Q3 24
-299.4%
Q2 24
-72.1%
Q1 24
5.6%
Net Margin
FVCB
FVCB
SURG
SURG
Q4 25
-85.6%
Q3 25
1341.1%
-40.1%
Q2 25
36.0%
-61.5%
Q1 25
1352.1%
-72.2%
Q4 24
-206.5%
Q3 24
1133.3%
-299.3%
Q2 24
1001.2%
-85.3%
Q1 24
373.3%
3.9%
EPS (diluted)
FVCB
FVCB
SURG
SURG
Q4 25
$0.31
$-0.68
Q3 25
$0.31
$-0.38
Q2 25
$0.31
$-0.36
Q1 25
$0.28
$-0.38
Q4 24
$0.27
$-1.07
Q3 24
$0.25
$-0.73
Q2 24
$0.23
$-0.66
Q1 24
$0.07
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FVCB
FVCB
SURG
SURG
Cash + ST InvestmentsLiquidity on hand
$1.7M
Total DebtLower is stronger
$13.3M
Stockholders' EquityBook value
$253.6M
$-15.3M
Total Assets
$2.3B
$8.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FVCB
FVCB
SURG
SURG
Q4 25
$1.7M
Q3 25
$2.5M
Q2 25
$4.4M
Q1 25
$5.4M
Q4 24
$11.8M
Q3 24
$23.7M
Q2 24
Q1 24
Total Debt
FVCB
FVCB
SURG
SURG
Q4 25
$13.3M
Q3 25
$12.0M
Q2 25
$9.6M
Q1 25
$3.6M
Q4 24
$4.0M
Q3 24
$4.4M
Q2 24
$4.8M
Q1 24
$5.2M
Stockholders' Equity
FVCB
FVCB
SURG
SURG
Q4 25
$253.6M
$-15.3M
Q3 25
$249.8M
$-6.4M
Q2 25
$243.2M
$116.1K
Q1 25
$242.3M
$7.8M
Q4 24
$235.4M
$15.3M
Q3 24
$230.8M
$33.2M
Q2 24
$226.5M
$46.2M
Q1 24
$220.7M
$56.0M
Total Assets
FVCB
FVCB
SURG
SURG
Q4 25
$2.3B
$8.5M
Q3 25
$2.3B
$14.5M
Q2 25
$2.2B
$15.2M
Q1 25
$2.2B
$15.7M
Q4 24
$2.2B
$24.0M
Q3 24
$2.3B
$41.5M
Q2 24
$2.3B
$56.4M
Q1 24
$2.2B
$69.6M
Debt / Equity
FVCB
FVCB
SURG
SURG
Q4 25
Q3 25
Q2 25
82.67×
Q1 25
0.46×
Q4 24
0.26×
Q3 24
0.13×
Q2 24
0.10×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FVCB
FVCB
SURG
SURG
Operating Cash FlowLast quarter
$23.9M
$-3.6M
Free Cash FlowOCF − Capex
$23.8M
FCF MarginFCF / Revenue
140.7%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$40.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FVCB
FVCB
SURG
SURG
Q4 25
$23.9M
$-3.6M
Q3 25
$7.6M
$-4.6M
Q2 25
$3.3M
$-6.1M
Q1 25
$5.4M
$-7.0M
Q4 24
$18.2M
$-7.9M
Q3 24
$4.7M
$-13.3M
Q2 24
$1.6M
$-4.1M
Q1 24
$7.2M
$4.0M
Free Cash Flow
FVCB
FVCB
SURG
SURG
Q4 25
$23.8M
Q3 25
$7.6M
Q2 25
$3.3M
Q1 25
$5.4M
Q4 24
$18.1M
Q3 24
$4.6M
Q2 24
$1.5M
Q1 24
$7.1M
FCF Margin
FVCB
FVCB
SURG
SURG
Q4 25
140.7%
Q3 25
1818.0%
Q2 25
20.8%
Q1 25
1413.6%
Q4 24
4786.0%
Q3 24
1121.8%
Q2 24
361.2%
Q1 24
1988.3%
Capex Intensity
FVCB
FVCB
SURG
SURG
Q4 25
0.3%
Q3 25
0.2%
Q2 25
0.1%
Q1 25
4.2%
Q4 24
37.3%
Q3 24
14.1%
Q2 24
12.8%
Q1 24
3.9%
Cash Conversion
FVCB
FVCB
SURG
SURG
Q4 25
Q3 25
1.36×
Q2 25
0.58×
Q1 25
1.05×
Q4 24
Q3 24
1.00×
Q2 24
0.37×
Q1 24
5.34×
3.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons